Last 48 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.99 | — | — | — | — | — | — | — | — | — | — | — | 184.25 | — | — | 30.51 | 47.59 | 63.82 | 67.44 | 2.48 | 4.93 |
| — | — | — | — | — | — | — | — | — | — | — | — | +287.1% | — | — | +1128.4% | +866.1% | +818.8% | -5.3% | -68.2% | +18.3% | |
| P/S Ratio | 0.28 | 0.30 | 0.37 | 0.41 | 0.69 | 0.69 | 0.80 | 0.85 | 1.05 | 1.05 | 0.87 | 1.13 | 1.67 | 1.64 | 2.08 | 1.77 | 1.65 | 1.54 | 2.09 | 1.19 | 2.25 |
| — | -55.9% | -53.1% | -52.2% | -34.7% | -34.7% | -9.0% | -24.6% | -37.1% | -35.8% | -58.0% | -36.2% | +1.0% | +6.7% | -0.6% | +48.5% | -26.6% | -47.7% | -72.8% | -67.9% | -7.0% | |
| P/B Ratio | 0.38 | 0.42 | 0.53 | 0.54 | 1.03 | 0.95 | 0.70 | 0.79 | 1.00 | 0.96 | 0.70 | 0.97 | 0.99 | 0.98 | 1.11 | 1.20 | 1.16 | 1.01 | 1.04 | 1.97 | 2.97 |
| — | -55.6% | -24.2% | -30.7% | +3.8% | -1.7% | -0.4% | -19.0% | +0.6% | -2.2% | -36.5% | -19.0% | -14.7% | -2.2% | +6.0% | -39.4% | -60.9% | -72.6% | -72.9% | -47.2% | -49.4% | |
| P/FCF | — | — | — | — | 5.73 | — | — | 7.78 | 45.05 | 10.73 | — | — | 38.99 | — | — | 12.16 | 13.30 | — | 6.48 | 2.49 | 4.96 |
| — | — | — | — | -87.3% | — | — | — | +15.5% | — | — | — | +193.1% | — | — | +388.2% | +168.1% | — | — | -9.3% | +3.9% | |
| EV / EBITDA | 10.02 | 8.18 | 10.26 | 10.94 | 25.17 | — | — | 8.81 | 156.09 | 11.08 | — | — | 11.99 | 13.28 | 23.06 | 9.85 | 10.20 | 11.63 | 15.11 | 1.43 | 3.24 |
| — | — | — | +24.2% | -83.9% | — | — | — | +1202.3% | -16.6% | — | — | +17.5% | +14.3% | +52.6% | +588.5% | +214.6% | +146.2% | -57.4% | -71.4% | +9.5% | |
| EV / EBIT | — | — | — | — | — | — | — | 36.73 | — | 68.57 | — | — | 50.37 | 59.54 | — | 20.76 | 26.46 | 31.30 | 37.26 | 1.47 | 3.37 |
| — | — | — | — | — | — | — | — | — | +15.2% | — | — | +90.4% | +90.2% | — | +1317.0% | +685.9% | +533.8% | -35.2% | -72.2% | +11.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.7% | 46.8% | 43.3% | 42.6% | 44.3% | 47.9% | 44.8% | 49.6% | 46.1% | 48.5% | 43.3% | 46.7% | 51.3% | 49.7% | 44.6% | 53.0% | 51.8% | 52.0% | 55.0% | 74.0% | 76.8% |
| — | -2.4% | -3.4% | -14.1% | -3.9% | -1.0% | +3.3% | +6.1% | -10.3% | -2.4% | -2.8% | -11.9% | -0.9% | -4.5% | -19.0% | -28.4% | -32.6% | -29.4% | -10.0% | -8.0% | -11.4% | |
| Operating Margin | -33.7% | -1.2% | -3.5% | -4.4% | -9.2% | -100.7% | -29.4% | 4.7% | -14.2% | 2.1% | -18.4% | -247.3% | 5.4% | 3.5% | -4.0% | 11.8% | 10.0% | 7.2% | 13.0% | 61.9% | 59.2% |
| — | +98.8% | +88.3% | -193.9% | +35.4% | -4981.2% | -59.6% | +101.9% | -362.7% | -41.6% | -356.1% | -2200.4% | -45.9% | -51.2% | -131.1% | -81.0% | -83.1% | -86.9% | -1.5% | +3.7% | -22.4% | |
| Net Margin | -41.5% | -8.7% | -14.7% | -14.8% | -18.1% | -104.7% | -41.6% | -1.8% | -25.2% | -2.7% | -23.2% | -239.9% | 0.9% | -1.7% | -8.0% | 5.8% | 3.5% | 2.4% | 3.1% | 47.9% | 45.7% |
| — | +91.7% | +64.6% | -708.0% | +28.3% | -3726.6% | -79.4% | +99.2% | -2774.0% | -60.3% | -189.9% | -4260.2% | -73.0% | -169.7% | -354.2% | -88.0% | -92.4% | -94.2% | -70.9% | +0.9% | -21.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -46.1% | -3.0% | -5.1% | -4.9% | -6.6% | -30.4% | -8.8% | -0.4% | -5.8% | -0.6% | -4.6% | -41.0% | 0.1% | -0.3% | -1.1% | 1.0% | 0.6% | 0.4% | 0.5% | 22.1% | 16.4% |
| — | +90.1% | +41.9% | -1046.4% | -14.3% | -4751.0% | -93.6% | +99.0% | -4218.0% | -145.6% | -328.3% | -4275.9% | -77.5% | -164.5% | -302.2% | -95.6% | -96.2% | -97.2% | -60.0% | +75.1% | -62.1% | |
| ROA | -18.6% | -0.9% | -1.6% | -1.6% | -2.3% | -12.2% | -4.0% | -0.2% | -2.7% | -0.3% | -2.2% | -22.3% | 0.1% | -0.1% | -0.6% | 0.6% | 0.3% | 0.2% | 0.3% | 17.4% | 12.8% |
| — | +92.3% | +58.8% | -717.3% | +15.3% | -4022.6% | -80.4% | +99.1% | -3394.3% | -98.5% | -259.4% | -4140.1% | -76.3% | -167.6% | -289.5% | -96.8% | -97.3% | -98.0% | -66.9% | +93.6% | -57.4% | |
| ROIC | -13.6% | -0.1% | -0.4% | -0.4% | -1.1% | -10.3% | -2.5% | 0.4% | -1.3% | 0.2% | -1.5% | -19.8% | 0.4% | 0.3% | -0.3% | 1.0% | 0.9% | 0.6% | 1.4% | 36.5% | 22.9% |
| — | +98.8% | +85.8% | -202.0% | +19.9% | -5450.9% | -63.3% | +102.2% | -430.2% | -26.3% | -460.6% | -2074.9% | -53.8% | -54.0% | -119.7% | -97.3% | -96.2% | -97.1% | -36.8% | +74.3% | -54.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.48 | 1.72 | 1.73 | 1.55 | 1.48 | 1.40 | 1.00 | 0.90 | 0.90 | 0.86 | 0.87 | 0.79 | 0.52 | 0.54 | 0.54 | 0.56 | 0.58 | 0.60 | 0.60 | 0.06 | 0.07 |
| — | +23.3% | +73.3% | +72.7% | +64.2% | +61.5% | +14.5% | +13.8% | +72.0% | +60.9% | +60.4% | +41.1% | -9.6% | -10.3% | -8.6% | +829.7% | +699.7% | +585.9% | +481.4% | -38.7% | -11.3% | |
| Debt / EBITDA | — | 27.51 | 32.41 | 33.62 | 61.34 | — | — | 19.29 | 301.28 | 21.51 | — | — | 16.81 | 19.15 | 31.09 | 13.08 | 14.03 | 17.86 | 23.05 | 0.23 | 0.36 |
| — | — | — | +74.3% | -79.6% | — | — | — | +1692.2% | +12.3% | — | — | +19.8% | +7.3% | +34.9% | +5622.0% | +3838.8% | +3581.7% | +460.9% | -63.0% | +106.6% | |
| Current Ratio | 1.50 | 1.36 | 1.39 | 1.43 | 1.50 | 1.78 | 1.12 | 1.20 | 1.22 | 1.38 | 1.44 | 1.55 | 1.57 | 1.59 | 1.66 | 1.65 | 1.56 | 1.66 | 1.73 | 4.29 | 4.45 |
| — | -23.9% | +23.5% | +19.1% | +22.8% | +29.4% | -22.0% | -22.7% | -22.4% | -13.8% | -13.1% | -5.8% | +0.5% | -3.7% | -4.4% | -61.5% | -64.9% | -57.2% | -60.5% | +22.7% | +31.3% | |
| Quick Ratio | 0.90 | 0.75 | 0.76 | 0.80 | 0.90 | 0.98 | 0.62 | 0.66 | 0.69 | 0.81 | 0.79 | 0.81 | 0.88 | 0.95 | 0.97 | 1.07 | 1.04 | 1.04 | 1.12 | 3.92 | 3.84 |
| — | -23.2% | +23.9% | +19.8% | +31.2% | +20.5% | -22.4% | -17.8% | -21.9% | -14.7% | -18.2% | -24.5% | -15.8% | -8.5% | -13.3% | -72.7% | -72.8% | -67.5% | -66.5% | +29.9% | +25.7% | |
| Interest Coverage | -5.24 | -0.14 | -0.48 | -0.62 | -1.61 | -15.38 | -4.05 | 0.79 | -2.15 | 0.42 | -2.41 | -55.11 | 0.80 | 1.07 | -0.68 | 3.22 | 2.40 | 2.01 | 5.01 | 3104.00 | 278.23 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying QDEL stock.
QuidelOrtho Corporation's current P/E is -2.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
QuidelOrtho Corporation's current operating margin is -33.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking QuidelOrtho Corporation's business trajectory between earnings reports.